Medications for Subarachnoid Hemorrhage

3 results

  • Nimodipine (nimodipine)

    (nimodipine)
    Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
    Usage: Nimodipine is indicated to improve neurological outcomes by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage due to ruptured intracranial berry aneurysms, applicable to all post-ictus neurological conditions (Hunt and Hess Grades I to V).

  • Nimodipine (nimodipine)

    (Nimodipine)
    Ascend Laboratories, LLC
    Usage: Nimodipine is indicated to improve neurological outcomes by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage resulting from ruptured intracranial berry aneurysms, regardless of the patient's post-ictus neurological condition (Hunt and Hess Grades I-V).

  • Nymalize

    (nimodipine)
    Azurity Pharmaceuticals, Inc.
    Usage: NYMALIZE is indicated for improving neurological outcomes in adult patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms, by reducing the incidence and severity of ischemic deficits, irrespective of the patients' neurological condition post-ictus (Hunt and Hess Grades I-V).